Literature DB >> 22760240

Managing metabolic syndrome in women.

Kelly Bosak1.   

Abstract

Cardiovascular disease (CVD) death rates in women in the United States are rising. This is attributed to the obesity epidemic and its contribution to cardiometabolic risk. Various gender-related factors and strategies must be considered to effectively manage metabolic syndrome in women and improve outcomes.

Entities:  

Mesh：

Year:  2012        PMID： 22760240      PMCID： PMC4129393          DOI： 10.1097/01.NPR.0000415871.60058.69

Source DB:  PubMed          Journal:  Nurse Pract        ISSN： 0361-1817


  36 in total

1.  Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study.

Authors:  Gerd Assmann; Paul Cullen; Helmut Schulte
Journal:  Circulation       Date:  2002-01-22       Impact factor: 29.690

2.  Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?

Authors:  Michael P Stern; Ken Williams; Clicerio González-Villalpando; Kelly J Hunt; Steven M Haffner
Journal:  Diabetes Care       Date:  2004-11       Impact factor: 19.112

3.  Hypertriglyceridemia as a cardiovascular risk factor.

Authors:  M A Austin; J E Hokanson; K L Edwards
Journal:  Am J Cardiol       Date:  1998-02-26       Impact factor: 2.778

Review 4.  A practical approach to risk assessment to prevent coronary artery disease and its complications.

Authors:  MacRae F Linton; Sergio Fazio
Journal:  Am J Cardiol       Date:  2003-07-03       Impact factor: 2.778

Review 5.  Nonexercise activity thermogenesis (NEAT): environment and biology.

Authors:  James A Levine
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-05       Impact factor: 4.310

6.  The distribution of 10-Year risk for coronary heart disease among US adults: findings from the National Health and Nutrition Examination Survey III.

Authors:  Earl S Ford; Wayne H Giles; Ali H Mokdad
Journal:  J Am Coll Cardiol       Date:  2004-05-19       Impact factor: 24.094

7.  Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project.

Authors:  R M Conroy; K Pyörälä; A P Fitzgerald; S Sans; A Menotti; G De Backer; D De Bacquer; P Ducimetière; P Jousilahti; U Keil; I Njølstad; R G Oganov; T Thomsen; H Tunstall-Pedoe; A Tverdal; H Wedel; P Whincup; L Wilhelmsen; I M Graham
Journal:  Eur Heart J       Date:  2003-06       Impact factor: 29.983

8.  Non-fasting serum triglyceride concentration and mortality from coronary heart disease and any cause in middle aged Norwegian women.

Authors:  I Stensvold; A Tverdal; P Urdal; S Graff-Iversen
Journal:  BMJ       Date:  1993-11-20

9.  LDL subclass phenotypes and triglyceride metabolism in non-insulin-dependent diabetes.

Authors:  K R Feingold; C Grunfeld; M Pang; W Doerrler; R M Krauss
Journal:  Arterioscler Thromb       Date:  1992-12

10.  Awareness of national physical activity recommendations for health promotion among US adults.

Authors:  Gary G Bennett; Kathleen Y Wolin; Elaine M Puleo; Louise C Mâsse; Audie A Atienza
Journal:  Med Sci Sports Exerc       Date:  2009-10       Impact factor: 5.411
View more
  1 in total

1.  Hyperglycemia enhances the proliferation of non-tumorigenic and malignant mammary epithelial cells through increased leptin/IGF1R signaling and activation of AKT/mTOR.

Authors:  Rebecca Lopez; Arunkumar Arumugam; Riya Joseph; Kanika Monga; Thiyagarajan Boopalan; Pamela Agullo; Christina Gutierrez; Sushmita Nandy; Ramadevi Subramani; Jose Manuel de la Rosa; Rajkumar Lakshmanaswamy
Journal:  PLoS One       Date:  2013-11-18       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.